Anti-Cancer Drugs

Editor(s): Sluyser, Mel

Publisher: Lippincott Williams & Wilkins (LWW)

2018 Journal Impact Factor: 1.801 (Journal Citation Report, Web of Science Group)

ISSN: 0959-4973

Register for eToc Alerts

Request a trial

Description

Reports both clinical and experimental results related to anti-cancer drugs, and includes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation.

This internationally refereed journal, devoted to the fast publication of innovative investigations on therapeutic agents against cancer, aims to stimulate and report research on both toxic and non-toxic anti-cancer agents. Consequently, the scope on the journal covers both conventional cytotoxic chemotherapy and hormonal or biological response modalities such as interleukins and immunotherapy.

Front File - 2015 to Present

Archives available for purchase

Details

Platform: Ovid
Publisher: Lippincott Williams & Wilkins (LWW)
Product Type: Journal
Author/Editor: Sluyser, Mel
ISSN: 0959-4973
Language: English
Update Frequency: 10 Times a year
Coverage: See Description

2018 Journal Impact Factor: 1.801 (Journal Citation Report, Web of Science Group)

Collections

Anti-Cancer Drugs

Resources of the Month

PsycBOOKS®

PsycBooks
 

Test Drive

Evidence Based Medicine Reviews

EBMR


Test Drive

The Journal of Urology®

JBJS


Test Drive

JBJS Journal of Orthopaedics for Physician Assistants

JBJS JOPA


Test Drive

Loading